Malamati Vreka
Munich, BY 81377, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Non-Oncogene Addiction of KRAS-Mutant Cancers to IL-1β via Versican and Mononuclear IKKβ.
Journal: Cancers
Published: February 16, 2023
Organ-restricted vascular delivery of nanoparticles for lung cancer therapy.
Journal: Advanced therapeutics
Published: April 22, 2021
KRAS signaling in malignant pleural mesothelioma.
Journal: EMBO molecular medicine
Published: October 22, 2020
Club cells form lung adenocarcinomas and maintain the alveoli of adult mice.
Journal: eLife
Published: January 28, 2019
IκB Kinase α Is Required for Development and Progression of KRAS-Mutant Lung Adenocarcinoma.
Journal: Cancer research
Published: June 29, 2017
Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion.
Journal: Nature communications
Published: April 08, 2017
BNN-20, a synthetic microneurotrophin, strongly protects dopaminergic neurons in the "weaver" mouse, a genetic model of dopamine-denervation, acting through the TrkB neurotrophin receptor.
Journal: Neuropharmacology
Published: December 07, 2016
Mutant KRAS promotes malignant pleural effusion formation.
Journal: Nature communications
Published: May 20, 2016
Comprehensive Evaluation of Nuclear Factor-κΒ Expression Patterns in Non-Small Cell Lung Cancer.
Journal: PloS one
Published: March 03, 2015
Mast cells mediate malignant pleural effusion formation.
Journal: The Journal of clinical investigation
Published: November 14, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026